A detailed history of Rosenberg Matthew Hamilton transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Rosenberg Matthew Hamilton holds 575 shares of TMO stock, worth $295,665. This represents 0.09% of its overall portfolio holdings.

Number of Shares
575
Previous 564 1.95%
Holding current value
$295,665
Previous $311,000 14.15%
% of portfolio
0.09%
Previous 0.09%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$531.86 - $624.21 $5,850 - $6,866
11 Added 1.95%
575 $355,000
Q2 2024

Jul 26, 2024

BUY
$541.52 - $599.02 $40,072 - $44,327
74 Added 15.1%
564 $311,000
Q1 2024

Apr 19, 2024

SELL
$528.82 - $599.43 $19,037 - $21,579
-36 Reduced 6.84%
490 $284,000
Q4 2023

Jan 12, 2024

BUY
$431.41 - $532.94 $8,196 - $10,125
19 Added 3.75%
526 $279,000
Q3 2023

Oct 11, 2023

BUY
$498.29 - $574.41 $22,423 - $25,848
45 Added 9.74%
507 $256,000
Q2 2023

Jul 26, 2023

SELL
$508.46 - $591.13 $65,591 - $76,255
-129 Reduced 21.83%
462 $241,000
Q1 2023

Apr 17, 2023

BUY
$535.0 - $604.82 $2,675 - $3,024
5 Added 0.85%
591 $340,000
Q4 2022

Jan 18, 2023

SELL
$484.71 - $571.37 $3,392 - $3,999
-7 Reduced 1.18%
586 $0
Q3 2022

Oct 21, 2022

BUY
$507.19 - $604.49 $13,694 - $16,321
27 Added 4.77%
593 $301,000
Q2 2022

Jul 15, 2022

BUY
$500.9 - $612.21 $37,567 - $45,915
75 Added 15.27%
566 $311,000
Q1 2022

Apr 14, 2022

BUY
$524.0 - $644.92 $19,912 - $24,506
38 Added 8.39%
491 $290,000
Q4 2021

Jan 20, 2022

BUY
$569.0 - $667.24 $95,592 - $112,096
168 Added 58.95%
453 $303,000
Q3 2021

Oct 12, 2021

BUY
$509.53 - $609.78 $61,653 - $73,783
121 Added 73.78%
285 $163,000
Q2 2020

Aug 04, 2020

BUY
$275.2 - $362.34 $45,132 - $59,423
164 New
164 $59,000

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $201B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Rosenberg Matthew Hamilton Portfolio

Follow Rosenberg Matthew Hamilton and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rosenberg Matthew Hamilton, based on Form 13F filings with the SEC.

News

Stay updated on Rosenberg Matthew Hamilton with notifications on news.